Company profile: Sividon Diagnostics
1.1 - Company Overview
Company description
- Provider of advanced diagnostics that facilitate therapeutic discovery, focused on improving the quality of companion diagnostics in oncology to support future cancer treatment decisions; based in Cologne, Germany, and formed via a management buyout from Siemens Healthcare Diagnostics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sividon Diagnostics
Fabric Genomics
HQ: United States
Website
- Description: Provider of genomics-driven precision medicine software, delivering end-to-end genomic analysis, interpretation, and clinical reporting for clinical labs, hospital systems, and country-sequencing programs. Powers actionable genomic insights to enable faster, more accurate diagnoses, featuring AI algorithms including GEM, VAAST, and Phevor for disease gene and phenotype-driven variant ranking.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fabric Genomics company profile →
Genomind
HQ: United States
Website
- Description: Provider of neuropsychiatry-focused precision medicine solutions, including pharmacogenetic (PGx) testing to personalize medication dosing and choices, software to identify gene–drug and drug–drug interaction risks and suggest safer alternatives, expert consults for staff training and patient-specific consultations, population health risk stratification, and in-person, virtual, and self-paced education.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomind company profile →
AccuraGen
HQ: United States
Website
- Description: Provider of cancer early detection solutions: a liquid biopsy platform using unique biochemistry and machine learning to extract cancer signals in plasma for treatment guidance, minimal residue disease detection, and early screening; and CLAmp-seq technology to detect multiple cancer signals in blood and analyze them with machine learning for multi-cancer early detection tests.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AccuraGen company profile →
IMGM Laboratories
HQ: Germany
Website
- Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMGM Laboratories company profile →
IBA Lifesciences
HQ: Germany
Website
- Description: Provider of life science technologies including the Strep-tag system for high-purity, high-yield recombinant protein purification and analysis; Strep-Tactin XT for strong, reversible binding to Twin-Strep-tag peptides; MagStrep Strep-Tactin XT beads and Strep-Tactin XT 4Flow resins for efficient purification; the MEXi mammalian cell production system; and StrepMAB-Immo for SPR analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IBA Lifesciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sividon Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sividon Diagnostics
2.2 - Growth funds investing in similar companies to Sividon Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sividon Diagnostics
4.2 - Public trading comparable groups for Sividon Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →